BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30516469)

  • 1. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii infection in two hospitals in Central Brazil: the role of ST730 and ST162 in clinical outcomes.
    de Azevedo FKSF; Dutra V; Nakazato L; Mello CM; Pepato MA; de Sousa ATHI; Takahara DT; Hahn RC; Souto FJD
    J Med Microbiol; 2019 Jan; 68(1):31-40. PubMed ID: 30516469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern Vietnam.
    Tuan Anh N; Nga TVT; Tuan HM; Tuan NS; Y DM; Vinh Chau NV; Baker S; Duong HHT
    J Med Microbiol; 2017 Jan; 66(1):46-53. PubMed ID: 28198682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of Carbapenem-Resistant
    Pagano M; Nunes LS; Niada M; Barth AL; Martins AF
    Microb Drug Resist; 2019 May; 25(4):538-542. PubMed ID: 30407115
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79).
    Chagas TP; Carvalho KR; de Oliveira Santos IC; Carvalho-Assef AP; Asensi MD
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):468-72. PubMed ID: 24880823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenem-resistant Acinetobacter baumannii: Current status of the problem in four Bulgarian university hospitals (2014-2016).
    Strateva T; Sirakov I; Stoeva T; Stratev A; Dimov S; Savov E; Mitov I
    J Glob Antimicrob Resist; 2019 Mar; 16():266-273. PubMed ID: 30412782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
    Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa.
    Agoba EE; Govinden U; Peer AKC; Osei Sekyere J; Essack SY
    Microb Drug Resist; 2018 Nov; 24(9):1289-1295. PubMed ID: 29653481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23.
    El Bannah AMS; Nawar NN; Hassan RMM; Salem STB
    Microb Drug Resist; 2018 Apr; 24(3):269-277. PubMed ID: 28783427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals.
    Correa A; Del Campo R; Escandón-Vargas K; Perenguez M; Rodríguez-Baños M; Hernández-Gómez C; Pallares C; Perez F; Arias CA; Cantón R; Villegas MV
    Microb Drug Resist; 2018; 24(1):48-54. PubMed ID: 28570118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital.
    Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA
    J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug- and Extensively Drug-Resistant
    Romanin P; Palermo RL; Cavalini JF; Fávaro LDS; De Paula-Petroli SB; Fernandes EV; Dos Anjos Szczerepa MM; Tognim MCB; Yamada-Ogatta SF; Carrara-Marroni FE; Yamauchi LM
    Microb Drug Resist; 2019 Nov; 25(9):1365-1373. PubMed ID: 31361565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated prevalence of multidrug-resistant Acinetobacter baumannii with extensive genetic diversity in the largest burn centre of northeast Iran.
    Sarhaddi N; Soleimanpour S; Farsiani H; Mosavat A; Dolatabadi S; Salimizand H; Amel Jamehdar S
    J Glob Antimicrob Resist; 2017 Mar; 8():60-66. PubMed ID: 28011349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.
    Schimith Bier KE; Luiz SO; Scheffer MC; Gales AC; Paganini MC; Nascimento AJ; Carignano E; Dalla Costa LM
    Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic and phenotypic characterisation of antimicrobial resistance in carbapenem-resistant Acinetobacter baumannii hyperendemic clones CC1, CC15, CC79 and CC25.
    Camargo CH; Cunha MPV; de Barcellos TAF; Bueno MS; Bertani AMJ; Dos Santos CA; Nagamori FO; Takagi EH; Chimara E; de Carvalho E; Tiba-Casas MR
    Int J Antimicrob Agents; 2020 Dec; 56(6):106195. PubMed ID: 33045346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.
    Mahamat A; Bertrand X; Moreau B; Hommel D; Couppie P; Simonnet C; Kallel H; Demar M; Djossou F; Nacher M
    Int J Antimicrob Agents; 2016 Jul; 48(1):51-55. PubMed ID: 27236843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in Bolivia.
    Sevillano E; Fernández E; Bustamante Z; Zabalaga S; Rosales I; Umaran A; Gallego L
    J Med Microbiol; 2012 Jan; 61(Pt 1):80-84. PubMed ID: 21873380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.